Authors:
Berry, DA
Muss, HB
Thor, AD
Dressler, L
Liu, ET
Broadwater, G
Budman, DR
Henderson, IC
Barcos, M
Hayes, D
Norton, L
Citation: Da. Berry et al., HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer, J CL ONCOL, 18(20), 2000, pp. 3471-3479
Citation: Pb. Lam et al., The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont, CANCER, 89(2), 2000, pp. 369-375
Authors:
Smith, TJ
Davidson, NE
Schapira, DV
Grunfeld, E
Muss, HB
Vogel, VG
Somerfield, MR
Citation: Tj. Smith et al., American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines, J CL ONCOL, 17(3), 1999, pp. 1080-1082
Authors:
Abrams, J
Aisner, J
Cirrincione, C
Berry, DA
Muss, HB
Cooper, MR
Henderson, IC
Panasci, L
Kirshner, J
Ellerton, J
Norton, L
Citation: J. Abrams et al., Dose-response trial of megestrol acetate in advanced breast cancer: Cancerand leukemia group B phase III study 8741, J CL ONCOL, 17(1), 1999, pp. 64-73